Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound. Disclaimer

LimitlessLab
Search the library Wishlist Cart, items: 0
Selank

Cognitive & Brain

Selank

Also known as TP-7, N-Acetyl Selank

Limited human evidencePrescription in some countries

Price range: €39 through €69

Discussed for: Anxiety, calm focus.

FIG. 2 ยท Amino-acid sequence of Selank (7 residues)
  1. T
  2. K
  3. P
  4. R
  5. P
  6. G
  7. P
  • Hydrophobic
  • Polar
  • Positive charge
  • Negative charge
  • Glycine / proline
Effect strengthHow hard it acts on the body4/10
Proof levelHow well that is shown in humans4/10
Risk levelHow much can go wrong2/10

Editorial 1 to 10 estimates from published research, not measured values. How to read these

Save to wishlist
Save to wishlist

01 / Identity

What it is

Selank is a synthetic heptapeptide (tuftsin analog). Main reported uses: anxiety, calm focus. Current status: prescription in Russia; FDA compounding concern (2023).

Molecule type
Synthetic heptapeptide (tuftsin analog)
How it is taken
Nasal spray
Other names
TP-7, N-Acetyl Selank

Route only. This library does not publish doses or protocols.

02 / Mechanism

How it is thought to work

Acts on GABA system and enkephalins, lowering anxiety

Mechanisms seen in cells or animals do not always happen the same way in people.

03 / Potential benefits

What people use it for

Anxiety, calm focus

Limited human evidence

Small or low-quality human data. Most of what is claimed comes from animals, cells or anecdotes.

Listed uses are what people use it for, not proven outcomes.

04 / Known risks

Side effects and risks

Fatigue, nasal irritation

Risk level 2 of 10

Lower risk score: reported side effects are mostly mild. Low risk is not no risk, especially for unregulated products.

Unknown long-term effects count as a risk, not as a clean record.

05 / Regulatory

Regulatory status

Status
Prescription in some countries
Details
Prescription in Russia; FDA compounding concern (2023)
Sport (WADA)
Not listed

Status reflects information up to mid-2026 and changes over time. Check current sources.

06 / Evidence quality

How good is the evidence?

Limited to moderate: mostly Russian studies

How we grade evidence

07 / Notes and sources

Notes and sources

  • In 2023 the FDA placed it on its list of bulk substances with significant safety concerns for compounding.
  • Anyone using compounds like this regularly should have medical supervision and bloodwork (for example IGF-1, glucose and HbA1c, hormones, lipids).
  • Source: Peptide Reference Table, an editorial review of published research up to mid-2026. Scores are 1 to 10 editorial estimates, not measured values. Regulatory and WADA status change over time.

Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound.

Related compounds